Cyxone AB (publ) (CYXO.ST)

SEK 0.02

(0.0%)

Total Debt Summary of Cyxone AB (publ)

  • Cyxone AB (publ)'s latest annual total debt in 2023 was 858 Thousand SEK , down -37.19% from previous year.
  • Cyxone AB (publ)'s latest quarterly total debt in 2024 Q2 was 470 Thousand SEK , down -29.32% from previous quarter.
  • Cyxone AB (publ) reported annual total debt of 1.36 Million SEK in 2022, down 0.0% from previous year.
  • Cyxone AB (publ) reported annual total debt of - SEK in 2021, down 0.0% from previous year.
  • Cyxone AB (publ) reported quarterly total debt of 470 Thousand SEK for 2024 Q2, down -29.32% from previous quarter.
  • Cyxone AB (publ) reported quarterly total debt of 1.33 Million SEK for 2023 Q1, down -2.05% from previous quarter.

Annual Total Debt Chart of Cyxone AB (publ) (2023 - 2015)

Historical Annual Total Debt of Cyxone AB (publ) (2023 - 2015)

Year Total Debt Total Debt Growth
2023 858 Thousand SEK -37.19%
2022 1.36 Million SEK 0.0%
2021 - SEK 0.0%
2020 - SEK 0.0%
2019 - SEK 0.0%
2018 - SEK 0.0%
2017 - SEK 0.0%
2016 - SEK 0.0%
2015 - SEK 0.0%

Peer Total Debt Comparison of Cyxone AB (publ)

Name Total Debt Total Debt Difference
Alligator Bioscience AB (publ) 16.09 Million SEK 94.67%
Ziccum AB (publ) 857 Thousand SEK -0.117%
Modus Therapeutics Holding AB (publ) - SEK -Infinity%
BioArctic AB (publ) 4.97 Million SEK 82.768%
Sprint Bioscience AB (publ) - SEK -Infinity%
Mendus AB (publ) 24.48 Million SEK 96.496%
Genovis AB (publ.) 79.32 Million SEK 98.918%
Intervacc AB (publ) 181 Thousand SEK -374.033%
QuiaPEG Pharmaceuticals Holding AB (publ) 20.61 Million SEK 95.837%
Active Biotech AB (publ) 3 Million SEK 71.4%
Magle Chemoswed Holding AB (publ) 60.3 Million SEK 98.577%
Bio-Works Technologies AB (publ) - SEK -Infinity%
Aptahem AB (publ) 5 Million SEK 82.84%
Vicore Pharma Holding AB (publ) - SEK -Infinity%
Kancera AB (publ) - SEK -Infinity%
Infant Bacterial Therapeutics AB (publ) - SEK -Infinity%
Fluicell AB (publ) - SEK -Infinity%
Saniona AB (publ) 71.4 Million SEK 98.798%
Lipigon Pharmaceuticals AB (publ) - SEK -Infinity%
Biovica International AB (publ) 7.82 Million SEK 89.039%
Spago Nanomedical AB (publ) - SEK -Infinity%
AcouSort AB (publ) - SEK -Infinity%
Xintela AB (publ) - SEK -Infinity%
Abliva AB (publ) 424 Thousand SEK -102.358%
Egetis Therapeutics AB (publ) 108.6 Million SEK 99.21%
Karolinska Development AB (publ) 3.07 Million SEK 72.052%
OncoZenge AB (publ) - SEK -Infinity%
Amniotics AB (publ) 2.58 Million SEK 66.744%
2cureX AB (publ) - SEK -Infinity%
CombiGene AB (publ) - SEK -Infinity%
Asarina Pharma AB (publ) 1 Million SEK 14.2%
Calliditas Therapeutics AB (publ) 979.13 Million SEK 99.912%
Camurus AB (publ) 24.5 Million SEK 96.499%
Corline Biomedical AB - SEK -Infinity%
IRLAB Therapeutics AB (publ) 27.56 Million SEK 96.887%
Isofol Medical AB (publ) - SEK -Infinity%
I-Tech AB - SEK -Infinity%
Hansa Biopharma AB (publ) 866.76 Million SEK 99.901%
ExpreS2ion Biotech Holding AB (publ) 1.71 Million SEK 49.854%
Biosergen AB - SEK -Infinity%
Cantargia AB (publ) - SEK -Infinity%
NextCell Pharma AB - SEK -Infinity%
Xspray Pharma AB (publ) 36.8 Million SEK 97.669%
Elicera Therapeutics AB (publ) - SEK -Infinity%
Nanologica AB (publ) 666 Thousand SEK -28.829%
SynAct Pharma AB 637 Thousand SEK -34.694%
Annexin Pharmaceuticals AB (publ) - SEK -Infinity%
Stayble Therapeutics AB (publ) 850 Thousand SEK -0.941%
LIDDS AB (publ) - SEK -Infinity%
Lipum AB (publ) 1.76 Million SEK 51.278%
BioInvent International AB (publ) 23.24 Million SEK 96.309%
Alzinova AB (publ) 800 Thousand SEK -7.25%
Oncopeptides AB (publ) 106.48 Million SEK 99.194%
Pila Pharma AB (publ) 773.08 Thousand SEK -10.985%
Guard Therapeutics International AB (publ) - SEK -Infinity%
Scandinavian ChemoTech AB (publ) - SEK -Infinity%
Simris Alg AB (publ) 90.74 Million SEK 99.054%
Diamyd Medical AB (publ) 30.67 Million SEK 97.203%
Xbrane Biopharma AB (publ) 231.47 Million SEK 99.629%
Ascelia Pharma AB (publ) 1.06 Million SEK 19.133%
Diagonal Bio AB (publ) - SEK -Infinity%